Abstract
Objective
To evaluate the favorite colors of patients with drug-resistant epilepsy.
Methods
Following examination, 50 patients were diagnosed in accordance with the 2005 proposal of the International League Against Epilepsy and the definition of drugresistant epilepsy since 2010. The favorite color examination used a six-color tape and Trycolors, an online color mixing tool. The patients' color preferences were compared with those of 50 individuals without epilepsy.
Results
Patients with drug-resistant epilepsy preferred the color blue the most (30%), significantly more yellow (p = 0.0001), and significantly less green (p < 0.0001) compared to individuals without epilepsy. By mixing these colors at a certain percentage, we obtained the Go Ben color.
Significance
This information on preferred colors can help to improve compliance and can be utilized in designing medications and environments for patients with epilepsy.
Similar content being viewed by others
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Hurlbert A, Owen A (2015) Biological, cultural, and developmental influences on color preferences. In: Elliot AJ, Fairchild MD, Franklin A (eds) Handbook of color psychology. Cambridge University Press, Cambridge, pp 454–477. https://doi.org/10.1017/CBO9781107337930.023
Racey C, Franklin A, Bird CM (2019) The processing of color preference in the brain. Neuroimage 191:529–536. https://doi.org/10.1016/j.neuroimage.2019.02.041
Bartolini E, Pesaresi I, Fabbri S, Cecchi P, Giorgi FS, Sartucci F, Bonuccelli U, Cosottini M (2014) Abnormal response to photic stimulation in juvenile myoclonic epilepsy: an EEG-fMRI study. Epilepsia 55(7):1038–1047. https://doi.org/10.1111/epi.12634
Palmer SE, Schloss KB (2010) An ecological valence theory of human color preference. Proc Natl Acad Sci USA 107(19):8877–8882. https://doi.org/10.1073/pnas.0906172107
Sable P, Akcay O (2011) Response to color: literature review with cross-cultural marketing perspective. Int Bull Bus Adm 11:34–41
Sirven JI (2016) Management of epilepsy comorbidities. Contin Lifelong Learn Neurol 22(1):191–203
Shlobin NA, Sander JW (2020) Drivers for the comorbidity of type 2 diabetes mellitus and epilepsy: a scoping review. Epilepsy Behav E&B 106:107043. https://doi.org/10.1016/j.yebeh.2020.107043
Hamed SA (2019) Ocular dysfunctions and toxicities induced by antiepileptic medications: types, pathogenic mechanisms, and treatment strategies. Expert Rev Clin Pharmacol 12(4):309–328. https://doi.org/10.1080/17512433.2019.1591274
Krauss GL (2009) Evaluating risks for vigabatrin treatment. Epilepsy Curr 9(5):125–129. https://doi.org/10.1111/j.1535-7511.2009.01315.x.PMID:19826501;PMCID:PMC2759040
Krauss GL, Johnson MA, Miller NR (1998) Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology 50:614–618
Ponjavic V, Gränse L, Kjellström S, Andréasson S, Bruun A (2004) Alterations in electroretinograms and retinal morphology in rabbits treated with vigabatrin. Doc Ophthalmol 108:125–133
Olney JW, Farber NB, Wozniak DF, Jevtovic-Todorovic V, Ikonomidou C (2000) Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain. Environ Health Perspect 108:383–388
Venters HD, Dantzer R, Kelley KW (2000) A new concept in neurodegeneration: TNF alpha is a silencer of survival signals. Trends Neurosci 23(4):175–180. https://doi.org/10.1016/s0166-2236(99)01533-7
Trojnar MK, Malek R, Chroscinska M, Nowak S, Blaszczyk B, Czuczwar SJ (2003) Neuroprotective effects of antiepileptic drugs. Pol J Pharmacol 54:557–566
Kunić S, Ibrahimagić OĆ, Vujković Z, Đajić V, Smajlović D, Mirković-Hajdukov M, Bećirović E, Kunić A, Tupković E (2022) Memory efficiency in patients with drug-resistant epilepsy. Acta Clin Belg 77(1):25–29. https://doi.org/10.1080/17843286.2020.1778347. (PMID: 32531177)
Leppik IE (1988) Compliance during treatment of epilepsy. Epilepsia 29(2):79–84. https://doi.org/10.1111/j.1528-1157.1988.tb05801.x
Fisher RS, van Emde BW, Blume W, Elger C, Genton P, Lee P et al (2005) Epileptic seizures and epilepsy: definition proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE). Epilepsia 46(4):470–472
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 51(6):1069–1077. https://doi.org/10.1111/j.1528-1167.2009.02397.x
Fisher RS, Cross JH, D’Souza C et al (2017) Instruction manual for the ILAE (International League Against Epilepsy) 2017 operational classification of seizure types. Epilepsia 58(4):531–542. https://doi.org/10.1111/epi.13671
Saito M (1996) A comparative study of color preferences in Japan, China and Indonesia, with emphasis on the preference for white. Percept Mot Skills 83(1):115–128
Crozier WR (1999) The meanings of colour: preferences among hues. Pigm Resin Technol 28(1):6–14
Pages N, Bac P, Maurois P, Durlach J, Agrapart C (2003) Comparison of a short irradiation (50 sec) by different wavelengths on audiogenic seizures in magnesium-deficient mice: evidence for a preventive neuroprotective effect of yellow. Magnes Res 16(1):29–34
Takahashi T, Nakasato N, Yokoyama H, Tsukahara Y (1999) Low-luminance visual stimuli compared with stroboscopic IPS in eliciting PPR in photosensitive patients. Epilepsia 40(Suppl 4):44–49. https://doi.org/10.1111/j.1528-1157.1999.tb00906.x
Harding GFA, Jeavons PM (1994) Photosensitive epilepsy, New. MacKeith Press, London
Harding GFA (1998) TV can be bad for your health. Nut Med 4:265–267
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
Conceptualization: SK and OCI; Methodology: SK, OCI and DS; Formal analysis and investigation: AK, ML, JA, AS, MT-C; Writing—original draft preparation: SK, AK, ML and JA; Writing—review and editing: OĆI. The corresponding author attests that all listed authors meet authorship criteria and no others meeting the criteria have been omitted. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
This study was approved by the Ethics Committee of the Primary Health Care Center Tuzla (approval number: 16-01-1669/16), in accordance with the ethical standards of the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all subjects involved in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kunić, S., Ibrahimagić, O.Ć., Smajlović, D. et al. Favorite colors of patients with drug-resistant epilepsy: pilot study. Acta Neurol Belg (2024). https://doi.org/10.1007/s13760-023-02457-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13760-023-02457-x